Home Home Home Inbox Home Search

Event

Early Clinical Response of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by PORT Risk Class: Results from the OPTIC Study

Location: PACIFIC BALLROOM 22
Session Type: Mini Symposium
Tuesday
May
22
9:30 AM
9:45 AM

Speaker(s)/Author(s)

Lynne Garrity-Ryan

PhD
Paratek Pharmaceuticals

Courtney Kirsch

BS
Paratek Pharmaceuticals

Anita Das

PhD
Paratek Pharmaceuticals

Paul B. Eckburg

MD
Paratek Pharmaceuticals

Paul McGovern

MD
Paratek Pharmaceuticals

Julio Alberto. Ramirez

MD, FACP
Univ of Louisville;University of Louisville

Evan Tzanis

BS
Paratek Pharmaceuticals

Amy Manley

BS
Paratek Pharmaceuticals

View Abstract

Early Clinical Response of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by PORT Risk Class: Results from the OPTIC Study

Parent Sessions

  • C17 - NEW INSIGHTS IN ACUTE PULMONARY INFECTIONS...
    05-22-2018 9:15 AM - 11:15 AM
    • Home Home Home Inbox Home Search